Drugs / B7H3-IL7Ra CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06612645 | Apr 2025 → Dec 2027 expected | childhood malignant neoplasm | Chulalongkorn University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B7H3-IL7Ra CAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06612645 ↗ |
| Modality | Cell therapy | “a type of immunotherapy called CAR T cells” NCT06612645 ↗ |
| Route | Intravenous | “administered via central venous access catheter after lymphodepletion” NCT06612645 ↗ |